chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had been running a temperature, I am usually 97.6 it was 99.1; I started to not feel good; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, on 18Jan2021 as a single dose, for COVID-19 immunization, lot number: unknown. Medical history included thyroid cancer and they took her thyroid (as reported). Concomitant medication included levothyroxine sodium (LEVOXYL) as she had thyroid cancer and they took her thyroid. Patient stated that she had first of her vaccine on 18Jan2021 (a week before the report was last Monday) and she felt fine, just the injection site (no further clarified). Starting on 23Jan2021 (reported as Saturday) she started to not feel good and on 24Jan2021 (reported as Sunday yesterday) she had been running a temperature, it was only like she was usually 97.6 it was 99.1 and she took paracetamol (TYLENOL) and it took the temperature down but she was wondering, patient called her doctor and she thought that it was too far, too many days have passed since the vaccination to have symptoms. Second dose scheduled for 08Feb2021. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Patient reports she received Moderna Covid 19 vaccine lot #039K20A on 12/26/2020. On 1/02/21 patient noticed swollen lymph nodes, left supraclavicular and axillary. Patient states "they were sore and almond size." Patient reports swelling was persistent for two weeks and patient scheduled appointment with her primary care. PCP ordered labs including cbc with diff, CRP, CR. Patient reports labs were normal.  Patient reports swelling decreased to pea size before she received second dose Moderna vaccine lot #039K20A on 1/20/2021. Patient reports lymph node swelling has again increased in size and effects left supraclavicular, axillary and groin. Patient denies any pain. Patient denies to see EHS. Patient plans to self monitor and will contact EHS with any changes. VAERS.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 31-JUL-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K016966, expiry date: 10-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
pt called on 5/24/21.  Pt c/o productive cough with greenish mucus, congestion, feeling sinus pressure from stuffy nose, feels tired, headache, chills on/off, loss of taste since 5/19/2021(wednesday) next day after he got his 2nd dose covid vaccine Pfizer on 5/18/2021. Pt speech clear. AO X3. Also denies emergency sx at this time. Scheduled an appt with urgent care provider telephone f/u 5/24/21 for further treatment and evaluation .Notified pt if  any emergency sx arises call 911 or go to nearest ED.
Mom states patient "woke up this morning with red spots on both legs and complaining they were itchy". Upon entering child was noted to have approximately 20-30 red spots on both legs. Approximately 6 lesions appeared vesicular all others were maculopapular. Vesicular lesions appear to be at injection site only. Treatment: Acyclovir 200mg/5ml 1tsp PO TID x 7 days.
Patient received first and second dose of the Pfizer vaccine- first dose: 2/16 Lot#EL3302 in the right arm. Second dose on 03/09/21, Lot#EN6204 in the left arm. On 03/29/21- patient tested positive for COVID-19 and was hospitalized.
Patient received 1 dose of COVID-19 MODERNA on 02/23/21. Then patient visited another pharmacy and requested 1 dose of PFIZER COVID-19 and it was administered as if it were his first dose of COVID-19, on 05/08/21. Patient then went to the pharmacy for a second dose of PFIZER on 05/28/21. Patient received 3 doses of covid-19 vaccines, he was advised not to request the booster.
Prickling Chest Pain Prickling headache at base of head Sore Gonads Pain in appendages Extreme acid reflux/dull chest pain Sharp diaphragmatic pain when stressed/irritated Bloating Reduced/No urge to urinate despote extremely full bladder
This is a spontaneous report from a contactable nurse calling on behalf of her mother. A 99 year-old female patient received the first dose of PREVNAR 13 via an unspecified route of administration in the right arm on 23Jan2015 at 0.5 ml single. The patient medical history was not reported. Concomitant medications were not specified, it was only mentioned that she was taking her unspecified regular medications at the time of the event. The patient did not receive any other vaccines on 23Jan2015. The patient has never had a problem with the pneumonia shot before. On an unspecified date in Jan2015 she complained of shoulder being sore, she developed a blood red rash that did not blanch when pressed, and it itched. The rash was from about 2 inches below her shoulder to about 1 1/2 inches above the fold in her elbow. The patient went to the doctor, he put her on antibiotics and told her to take BENADRYL and PEPCID AC. When the rash got bigger, he went to the emergency room, where they gave her a prescription for a prednisone dose pack for 4 days and they told her to continue taking the antibiotics that her doctor had given her. She was not admitted to the hospital. Rash has still not resolved. It has not worsened further but it has not improved either. Outcome of sore shoulder was unknown. Follow-up (13Mar2015): Follow-up attempts completed. No further information expected.
Headache, Myalgia, Fever & NauseaVomiting  Narrative:   Other Relevant History:
Information has been received from a health professional concerning a 30 year old male with no past medical history who on 05/09/2001 was vaccinated IM with hep b vaccine recombinant. There was no concomitant therapy. On 05/10/2001 the pt experienced headache and generalized aches. This was severe enough that the pt did not work for one day. Subsequently, the pt recovered from headache and generalized aches. No other info is available.
Patient was given a vaccine and was under the age of 18 at the time.  No visable adverse reactions were seen or reported at the time.  Patient should not have received the vaccine according  to the Moderna VIS sheet.
Pneumovac administered on Friday, 11/29. On Saturday 11/30 I had some pain and redness around injection site. By Sunday 12/1, redness had increased down the inside of my arm and now was raised, extremely painful. Area was marked and watched with improvement of pain/swelling with 1gram acetaminophen.
Inadvertant administration of > thanrecommended dose. Vial was notreconstituted with diluent and patientreceived 0.3ml of undiluted vaccine; Inadvertant administration of greater than recommended dose.; This is a spontaneous report from a contactable pharmacist, the patient. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an intramuscular route of administration on left arm on 19Mar2021 at 9:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. The patients allergies to medications, food, or other products were NKDA. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient was pregnant. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. It was unknown if the patient has tested for COVID-19 since the vaccination. Concomitant medication not reported. On 09Mar2021 at 9:30 the patient had inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and the patient received 0.3ml of undiluted vaccine. The clinical outcome for the event inadvertant administration of greater than recommended dose, vial was not reconstituted with diluent and patient received 0.3ml of undiluted vaccine was unknown.  No follow-up attempts are possible. No further information is expected.
Cough after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough after 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough after 1st dose). At the time of the report, COUGH (Cough after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant  concomitant medications provided. No relevant treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: No newinformation
Received Tdap vaccine, 24 hours later had vomiting every 10 minutes for 6 hours. Since then without problems except slight soreness to arm. Missed 1 day of work.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. The concurrent conditions and medical history of the patients were not reported. Concomitant therapies included sterile diluent. On unknown dates, the patients were vaccinated with multiple improperly stored doses of VARIVAX with lot # M043582 and expiration date of 28-OCT-2018 (strength, dose and route of administration were unknown) for prophylaxis, which were stored from -14 Celsius degrees (°C) to -10°C (-14°C) and from -9°C to 8°C (-7°C) for 50 hours. There were no previous temperature excursions. Moreover, it was reported that the temperature excursions were detected by a data logger. No adverse events were reported. As of 23-MAY-2018, all telephone attempts to obtain follow-up information have been unsuccessful. Follow up information was received from the registered nurse on 05-DEC-2018, who stated that another improperly stored doses of VARIVAX lot # R017643 with expiration date of 20-JUN-2020 (which was stored at -3.9 Celsius for 40 hours), and lot # R017643 with expiration date of 02-JUL-2018 (which was stored at -13.7 Celsius for 5 hours and 51 minutes)  were administered also for prophylaxis There were no previous temperature excursions. The diluent was properly stored (lot and expiration date were not reported).
Information has been received from a Certified Medical Assistant through Merck Pregnancy concerning a 23 year old female patient with moderate dysplasia of the cervix and a history of loop electrosurgical excision procedure (LEEP) who on 02-JAN-2007 was vaccinated IM in right deltoid with a first dose of Gardasil and had menstruation cycle on that day. On 27-FEB-2007 the patient was vaccinated IM in right deltoid with a second dose of Gardasil. Concomitant therapy included Mirena IUD birth control. On 05-MAR-2007 the patient presented to office experiencing nausea. Urine pregnancy test was performed and it was positive for pregnancy. The reporter stated that client had unusual history; her birth control was a Mirena IUD but on manual examination it was not found. The MA stated that it must have expulsed. She had a cervical smear (PAP) test done which showed moderate dysplasia. On 04-NOV-2006 patient had Leep procedure performed. The patient's outcome was unknown. Additional information has been requested.
Patient given wrong dose of vaccine ordered. Misunderstanding of which dose was to be given to Pediatric patient.
Ten minutes post vaccine administration, patient complained of chest pain, swelling of the lips, headaches, tachycardia. Benadryl and Epi were administered. Paramedics were called to site, and patient was transferred to ER.
Case number PHEH2014US019197 is an initial spontaneous report received from a nurse on 19 SEP 2014. This report refers to a 23 year old male patient. His medical history and concomitant medication were not reported. On 18 SEP 2014, he was inadvertently vaccinated with FLUVIRIN 2014/2015 (batch number: 1412001) intramuscularly at a dose of 01 ml instead of the recommended 0.5 ml dose. No adverse event was reported following this medication error (overdose).
Welts on both sides, flu like symptoms, pain. Taking ibuprofen and diphenhydramine.
Patient came to an external clinic to receive a booster shot. I had verified both the patient's QR code and vaccination card and it had shown only two dates. However when we tried to process the booster, it stated that he had received his 3rd vaccination on 10/08/2022 at another store. I had called the patient to verify this but he could not recall receiving the booster at that time so I had called the other store to verify with personnel there and confirmed that he did receive it then. So without that knowledge at the clinic set up outside of the pharmacy, I had administered another 'booster' on 1/27/2022. I had followed up with the patient and he has stated that he is fine without side effects at this time.
feeling a little off in my stomach; hiccups; burping; vomiting; nausea; muscle aches and pains/ pain all over; pins and needles; tired; fever of 101 point something; brain was messed up; lethargic / couldn't get out of bed; soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping) and FEELING ABNORMAL (brain was messed up) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastritis (Gastrointestinal issues) and Diverticulitis (Gastrointestinal issues).    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced VACCINATION SITE PAIN (soreness in her arm). On 06-Jun-2021, the patient experienced FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired). On 07-Jun-2021, the patient experienced PARAESTHESIA (pins and needles) and MYALGIA (muscle aches and pains/ pain all over). On 10-Jun-2021, the patient experienced HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (feeling a little off in my stomach). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency; CEFIXIME (FLEXERIL [CEFIXIME]) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and NAPROXEN at a dose of 1 dosage form. On 05-Jun-2021, VACCINATION SITE PAIN (soreness in her arm) had resolved. On 06-Jun-2021, FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired) had resolved. At the time of the report, PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown and MYALGIA (muscle aches and pains/ pain all over) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Body temperature: 101 (High) Had fever of "101 point something.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also experienced "up chucking" and a pins and by needles feeling patient deemed the "movie theater experience."   No concomitant medications were reported. The patient reported she saw her HCP for her symptoms.
SUPERFICIAL THROMBOPHLEBITIS; This spontaneous report received from a patient and concerned a 40 year old white, not Hispanic or Latino female. The patient's height, and weight were not reported. The patient's concurrent conditions included varicose veins. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, frequency 1 total administered on 17-MAR-2021 to Left deltoid in arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 30-MAR-2021 and on 31-MAR-2021, the patient experienced severe leg pain on right side. Patient tried hot and cold compress. The patient wore compression stockings but nothing helped. Patient went to doctor on 13-APR-2021 and doctor diagnosed Superficial thrombophlebitis. The patient planned to get ultrasound on 14-APR-2021, next day, at 6 pm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from superficial thrombophlebitis. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: A 40-year-old woman with a history of varicose veins experienced superficial thrombophlebitis 13 days after vaccine. An ultrasound was planned to confirm the diagnosis. Varicose veins provide a plausible alternate risk factor for the event. However, there is insufficient information to make a meaningful medical assessment. Additional information has been requested, including the ultrasound report.
Patient stated they had extreme redness and swelling in the arm they received both vaccines in and went to the emergency room where she was diagnosed with cellulitis and treated with antibiotics.
MD requiring 2nd series of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of off label use in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included stem cell transplant. Previously administered products included Shingrix (received a series of Shingrix vaccination on an unknown date).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced off label use. On an unknown date, the outcome of the off label use was unknown.   Additional Information: GSK receipt date: 12-Apr-2022 Reporter's comments: Pharmacist reported that the patient had stem cell transplant and doctor of medicine (MD) requiring 2nd series of Shingrix vaccinations. The original dates of 1st Shingrix vaccination series unknown. The reporter refused to provide any patient demographics. The reporter consented to follow-up. Additional Supportive Information: The reporter reported that doctor of medicine (MD) requiring 2nd series of Shingrix vaccinations, which led to off label use.
27MAY98 pt visited clinic & reported constant h/a in the back of head since the evening of 19MAY98;approx 24hr p/vax;also working noc & had been doing a lot of mopping floors;h/a would diminish but remained used advil;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. On 5th August 2018, the patient received the 1st dose of SHINGRIX. In August 2018, 2 hrs after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling, headache, gut pain, fever, chills, weakness, appetite lost, tingling sensation and skin blotches. On an unknown date, the outcome of the injection site pain, injection site swelling, headache, gut pain, fever, chills, weakness, appetite lost, tingling sensation and skin blotches were unknown. It was unknown if the reporter considered the injection site pain, injection site swelling, headache, gut pain, fever, chills, weakness, appetite lost, tingling sensation and skin blotches to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received  SHINGRIX in left arm. The patient declined to provide full demographics for herself. Less than a week after receiving SHINGRIX, the patient experienced headache, gut pain, fever, chills, weakness, loss of appetite, blotchy skin down her legs and tingling sensation in the skin around her abdomen.
Pt recvd vax & exp a fever fo 102, nausea, vomiting & body aches; fever was treated w/APAP & resolved w/o problems; pt exposed to family viral illness;
Pt states that on 4/14/2021 one day post vaccination she began to break out with hives. Stated hives started on neck and chest. Stated that after testing positive for COVID 19 she also had rash and hives. 4/22/2021 large, red hives noted to upper chest and neck. Red raw skin noted over area. C/O severe itching. 4/22/2021 Encouraged to call medical provider regarding condition and seek follow up care.
Non Moderna Vaccine (Second Vaccine); Ringing on left side of ear; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing on left side of ear) and INTERCHANGE OF VACCINE PRODUCTS (Non Moderna Vaccine (Second Vaccine)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced TINNITUS (Ringing on left side of ear). On 18-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Non Moderna Vaccine (Second Vaccine)). At the time of the report, TINNITUS (Ringing on left side of ear) outcome was unknown and INTERCHANGE OF VACCINE PRODUCTS (Non Moderna Vaccine (Second Vaccine)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication and treatment drug were not reported.    Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Case Received From removed. Action taken added in product tab. Tinnitus deleted as additional event. Outcome updated to resolved for Interchange of vaccine products.
Arm soreness-started right away and resolved after 48 hours Migraine-started approximately 12 hours after vaccination and resolved 48 hours after vaccination
Hospitalized for COVID 19 on 7/31/2021, had COVID 19 also in 03/21
Redness, itching at injection site that progressed to streaking and wheezing, coughing, chest tightness, anxiety.
Severe body ache. Fever. Chills. Headache. Nasal congestion. Actually thought I was going to die. From 1am until 10am
Sudden hearing loss, ringing in the ears followed by severe vertigo and hearing loss, hearing loss came on suddenly after 2-3 days of ringing in the ears, hearing has come back some but very little, vertigo went away after initial attack
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult female patient who received MENVEO. On 9th January 2016, the patient received MENVEO. On 27th January 2016, 18 days after receiving MENVEO, the patient experienced headache. On an unknown date, the outcome of the headache was unknown. The reporter considered the headache to be unrelated to MENVEO. Additional details provided were as follows: This case was reported by the patient herself. The patient was in her 30s and did not have weakened immune system or diabetes.
Patient said after getting the vaccine her arm has had constant pain in it. Has been experiencing pain currently.  Patient felt that the immunization was given too high.
Fever, 102- treating with iboprofen. Cough, chest congestion, treating with mucinex. Extreme fatigue, muscle aches, bone pain, treating with rest and fluids.